Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis.
about
Potential function of miRNAs in herpetic stromal keratitisLipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectivesPathogenesis of herpes stromal keratitis--a focus on corneal neovascularizationClinical correlates of common corneal neovascular diseases: a literature reviewTopical Use of Angiopoietin-like Protein 2 RNAi-loaded Lipid Nanoparticles Suppresses Corneal NeovascularizationGene delivery to cornea.Short interfering RNA (siRNA) as a novel therapeutic.Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathyAdvances in Systemic siRNA DeliveryVEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.Targeted suppression of HO-2 gene expression impairs the innate anti-inflammatory and repair responses of the cornea to injury.Herpes simplex virus keratitis: histopathology and corneal allograft outcomesEfficient and targeted delivery of siRNA in vivo.Herpes keratitis.Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma.Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colon.Corneal neovascularization: an anti-VEGF therapy review.Corneal lymphangiogenesis in herpetic stromal keratitisNanomedicine in GIPEI-g-PEG-RGD/small interference RNA polyplex-mediated silencing of vascular endothelial growth factor receptor and its potential as an anti-angiogenic tumor therapeutic strategyActivation of endothelial roundabout receptor 4 reduces the severity of virus-induced keratitis.An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology.Transfection of shRNA-encoding Minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cellsNanotechnology for energy-based cancer therapiesInfluence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latencyCorneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)Harnessing RNAi nanomedicine for precision therapyIL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infectionRobo 4 Counteracts Angiogenesis in Herpetic Stromal KeratitisInhibition of experimental corneal neovascularisation by bevacizumab (Avastin)Nanoparticle-mediated delivery of shRNA.VEGF-a plasmids regresses corneal neovascularizationSilencing of Rac1 expression via RNA interference inhibits retinal neovascularization in rats.Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitissiRNA-mediated inhibition of angiogenesis.Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus.Suppression of transcription factor early growth response 1 reduces herpes simplex virus 1-induced corneal disease in miceInhibition of VEGF expression and corneal neovascularization by siRNA targeting cytochrome P450 4B1.Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders.The silent treatment: siRNAs as small molecule drugs.
P2860
Q26823201-50771B21-9941-4A50-8559-8D6414C4C262Q26859021-1C3F6E68-BFFD-49B9-BD27-BCC629B11EFBQ27023951-4E22E188-93BF-49BD-B5F8-DEF93D5886C4Q28257676-C0198951-F6D0-4927-BAB6-2F8D1BA7BCA8Q28831101-EDB5644D-8976-4C9C-A7B2-B5753AC6DC93Q30476991-273385F1-8F40-4B27-9244-AB1AD48BA50DQ33243420-51C1537D-86E1-4202-A66C-8B6FED7ECB24Q33379554-1F7D2F99-D965-4776-B925-960E0C42EEECQ33613316-E71FD591-0E1A-4C1B-946B-F04581C3949DQ33615188-9DF8057C-6D21-4A88-8976-DF66390D5C28Q33692555-139B7ED4-54B6-4AB7-A7CC-2C93144985C0Q33892448-9160CF76-68A8-41F1-82A8-F107B139D03FQ33904084-90E43899-E584-48AE-B723-50747FC1371AQ34149828-BC70C152-4635-478B-9059-E1984C7D1A47Q34297293-3E27BC54-28B3-434E-897B-0184927070E8Q34334362-1A1A88A7-72D1-472A-BAE2-91514E459163Q34354205-9AB63EFF-9B54-4759-91F3-08C1397F6C06Q34641522-4D116C3E-C740-4D88-A5E1-7329AA714ECFQ34674612-2A13025B-F484-4BEA-AC91-E5237130615EQ34719056-1CE7170E-8C10-42A1-A1E3-5191C9BE029CQ34805909-B763CF59-F277-43DD-95FB-92B609289051Q35037318-21D356B5-1964-4376-BBE6-3B4EA418DE97Q35076957-1B7BC353-1FAF-4A05-A849-E44C999BC3A7Q35159211-AFF4815C-DDF5-4F22-8060-3CC28297DFADQ35264028-B1A4CDCF-4791-439B-A3E0-0EAB1DECD150Q35566669-2A88F08F-A05D-49D9-9288-8685E2C4E40CQ35662667-EF2A4CDC-1B20-4047-B786-38A3D3A39695Q35673875-F5C6E145-7D7C-41BD-95CA-5BF4401EBF0FQ35850771-D0BBE365-ECE6-4B6B-BC78-119E661A0FDCQ35882555-1B52963E-35EA-4956-AA1F-665506BA0CA3Q35956190-99E93925-3D2C-4F6C-8D40-0779E153EEF4Q36009031-0D2A5E8F-6862-4163-B76D-135FF48BFF71Q36015790-2C3AD5E7-1025-4BBA-A8CD-BAF6329FF372Q36099335-A75DB33B-2479-45EA-B72D-386E139AEF88Q36099464-CF805009-26C6-4483-BDD3-A98EAF35623BQ36131519-9E14F44F-A460-404D-B30E-FC026B4CF357Q36171987-46CD88FB-CFAF-41F3-814C-A0BDD733F453Q36248876-7F27DF22-0BBE-4BDE-932D-520A15FD4372Q36272954-C62A7CD3-F0F0-45BA-B959-667D85A43FABQ36362370-9D3612AA-3C55-413B-A64E-CD18685BBD0C
P2860
Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Inhibition of ocular angiogene ...... or herpetic stromal keratitis.
@ast
Inhibition of ocular angiogene ...... or herpetic stromal keratitis.
@en
type
label
Inhibition of ocular angiogene ...... or herpetic stromal keratitis.
@ast
Inhibition of ocular angiogene ...... or herpetic stromal keratitis.
@en
prefLabel
Inhibition of ocular angiogene ...... or herpetic stromal keratitis.
@ast
Inhibition of ocular angiogene ...... or herpetic stromal keratitis.
@en
P2093
P2860
P1476
Inhibition of ocular angiogene ...... or herpetic stromal keratitis.
@en
P2093
Aslam M Ansari
Barry T Rouse
Bumseok Kim
Frank Y Xie
Martin C Woodle
Partha S Biswas
Patrick Lu
Puthupparampil V Scaria
Qingquan Tang
P2860
P304
P356
10.1016/S0002-9440(10)63267-1
P407
P577
2004-12-01T00:00:00Z